Impact of Ginger on Menopausal Symptoms
Impact of Zingiber Officinale on Symptoms and Hormonal Changes During the Menopausal Period in Duhok -Iraq
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aimed to examine the impact of one gram of Zingiber Officinale powder on menopausal symptoms since a large number of menopausal women in this region (Duhok city in the North of Iraq) are reluctant to take the conventional treatment for improving their menopausal symptoms and they prefer of taking the ginger powder and surprisingly many of those patients reported positive effects on their symptoms and general well being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 7, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedAugust 12, 2022
August 1, 2022
3 months
August 7, 2022
August 11, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Impact of Zingiber Officinale on hot flush in menopausal women
A significant change in the intensity of hot flushes was observed in the menopausal rating scale in menopausal women treated with ginger powder compared to pre-treatment.
six weeks treatment with Zingiber Officinale powder
Impact of Zingiber Officinale on Night sweating in menopausal women
A significant change in the intensity of night sweating was observed in the menopausal rating scale in menopausal women treated with ginger powder compared to pre-treatment.
six weeks treatment with Zingiber Officinale powder
Impact of Zingiber Officinale on estrogen levels in menopausal women
A significant change was observed in serum estrogen levels in menopausal women treated with ginger powder compared to pre-treatment.
six weeks treatment with Zingiber Officinale powder
Impact of Zingiber Officinale on body weight in menopausal symptoms
A significant change was observed in body weight in kilograms in menopausal women treated with ginger powder compared to pre-treatment.
six weeks treatment with Zingiber Officinale powder
Study Arms (2)
Treatment group (Ginger)
EXPERIMENTALAll the participants were given Zingiber Officinale powder (500 mg) capsules twice daily for twelve weeks. Zingiber Officinale capsules were purchased from Pure Mountain Botanicals, 1712 Pioneer Ave # 1139 Cheyenne Wyoming 82001 (USA)
Control group (Placebo)
PLACEBO COMPARATORAll the participants were given starch powder (50 mg) capsules twice daily for twelve weeks.
Interventions
Ginger powder
Eligibility Criteria
You may qualify if:
- Women living in Duhok city with self-reported menopause symptoms
- Aged between 45 and 60 years
You may not qualify if:
- Not on treatment for menopausal symptoms
- Patients Having chronic diseases like hypertension, Ischemic heart diseases or Diabetes mellitus
- Patients having coagulopathies
- Patient's having hormone-dependent malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Duhok College of Pharmacy
Duhok, Kurdistan Region, 42001, Iraq
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- A pharmacist professional was responsible for distributing the treatment (ginger) and placebo and he was in charge to assign the participants to the groups.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc Student in clinical Pharmacology
Study Record Dates
First Submitted
August 7, 2022
First Posted
August 12, 2022
Study Start
December 1, 2021
Primary Completion
March 1, 2022
Study Completion
June 1, 2022
Last Updated
August 12, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share
The collected Data will not be shared until the study has been published